Floatz logo

Compound Edaravone

Endovascular Thrombectomy

Hui-Sheng ChenPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Endovascular Thrombectomy cohort.

Asset / SponsorPhaseRating
Hydralazine
Hamilton Health Sciences Corporation
Phase 2B
LABETALOL
Hamilton Health Sciences Corporation
Phase 2B
Tenecteplase
Yi Yang
Phase 2/3B
Nicardipine
University of Cincinnati
Phase 2B
Arestin
Xiang Luo
Phase 2/3B

View all 10 →

Same molecule, other indications

Compound Edaravone is also rated in:

ischemic strokeDormant
BBB
Indicative ·
73 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
66 / 100
View asset →
cerebral infarctionDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →